Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Syntec Optics (Nasdaq: OPTX), Achieves New Milestone, Makes 17,000th Space Optics
-
EXL announces appointment of Patrick Geraghty to Board of Directors
-
Akebia Therapeutics Announces Five Presentations at ASN Kidney Week 2025
-
IMUNON Hosts R&D Day Highlighting Progress on OVATION 3 Study in Pursuit of First Frontline Immunotherapy for Advanced Ovarian Cancer
-
IMUNON Hosts R&D Day Highlighting Progress on OVATION 3 Study in Pursuit of First Frontline Immunotherapy for Advanced Ovarian Cancer
-
HydroGraph to Present at the Emerging Growth Conference on October 23, 2025
-
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network and Appointment of Dr. Rebecca Cohen as HOPE
-
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network and Appointment of Dr. Rebecca Cohen as HOPE Med
-
Jackson County Detention Center Selects Liberty Defense’s HEXWAVE for Checkpoint Security Screening
-
Primary Endpoint Met in EFTISARC-NEO Phase II Evaluating Neoadjuvant Efti in Soft Tissue Sarcoma and Data Presented at ESMO Congress 2025
-
VEPO Solutions Promotes Tom Moore to President to Drive Continued Growth and Innovation
-
R1 Announces Strategic Partnership with Sierra to Revolutionize AI-Driven Experiences in Healthcare
-
ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025
-
BioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc.
-
Phathom Pharmaceuticals to Report Third Quarter 2025 Financial Results and Provide Business Update on Thursday, October 30, 2025
-
Arnatar Therapeutics Announces Upcoming Presentations at AASLD The Liver Meeting® 2025 and ASN Kidney Week 2025
-
Galectin Therapeutics to Present at the H.C. Wainwright 9th Annual MASH Investor Conference
-
CervoMed to Present at the Emerging Growth Conference
-
Maxus Mining Announces Appointment of Robert Eckford as Technical Advisor & Marketing Agreement
-
WiMi Develops Single-Qubit Quantum Neural Network Technology for Multi-Task Design
-
Vaxart to Present Research on Second-Generation Norovirus Oral Pill Vaccine Candidate at IDWeek 2025
-
STRATA Skin Sciences Reinforces Market Leadership Following Key Litigation Milestones Against LaserOptek
-
Judo Bio Presents Data Demonstrating Sustained, Kidney-Selective Gene Silencing Across Species
-
GSI Technology to Announce Fiscal Second Quarter 2026 Results on October 30, 2025
-
Cyber Advice Announces Launch of New Website
-
Aqua Metals Closes $13 Million Capital Raise with Prominent Institutional Investor, Company Poised to Accelerate Commercialization Strategy
-
Connect Expands Access to Funding Through Curated Venture List
-
BioAtla Presents Promising Interim Data from its Phase 1 Trial with BA3182 in Patients with Treatment Refractory Metastatic Adenocarcinoma at ESMO 2025
-
Oportun Completes $441 Million Asset Backed Securitization
-
Valitor Presents Preclinical Data Demonstrating VLTR-559 Achieves Superior Durability and Sustained Anti-VEGF Activity with a Favorable Safety Profile as a Treatment for Wet AMD
-
MBX Biosciences to Participate in November Investor Conferences
-
Commerce Introduces BigCommerce Payments Powered by PayPal
-
Evergreen Line selects ORBCOMM’s smart dry container solutions
-
Adaptyx Raises $14M in Seed Financing to Launch Wearable Platform for Continuous Multi-Analyte Molecular Monitoring
-
Volaris Group Acquires Fintilect
-
Reverba Global Introduces ClinOps G.P.S.™ to Set a New Course for Clinical Trial Execution and Chart a Clearer Path from Protocol to Completion
-
STMicroelectronics announces status of common share repurchase program
-
Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs
-
Classiq Partners with QUCAN to Deliver Hands-On Quantum Training Globally
-
Genius Group CEO Roger Hamilton buys additional shares, increasing 2025 share purchases by 17%.
-
Bakkt Strengthens Board with Appointment of Renowned Macro Strategist Lyn Alden
-
FG Nexus Initiates $200 Million Share Buyback Program
-
Aeries Technology Expands Private Equity Partnerships with New Client Engagement in Mexico
-
Indonesian Media Test Drives the OMODA 9 SHS on Track for the First Time, Experiencing the World’s Exclusive Quad-Motor AWD PHEV Technology
-
Oncotelic to Present at the LD Micro Main Event XIX
-
RAPT Therapeutics and Shanghai Jeyou Pharmaceutical Announce Positive Topline Data from Phase 2 Trial of RPT904 (JYB1904) in Chronic Spontaneous Urticaria
-
ProCap BTC to Appoint Renae Cormier as Chief Financial Officer
-
Synergy CHC Corp. (NASDAQ: SNYR) Expands FOCUSfactor® Functional Beverages Across New England Through Atlantic Importing Alliance
-
Two Posters at ESMO Congress 2025 Highlight Immutep’s Focus on Changing Treatment Landscape in First Line Non-Small Cell Lung Cancer
-
NANO Nuclear Included in Morgan Stanley’s National Security Index
